Eurofins: H1 adjusted earnings up 19%
(CercleFinance.com) - Eurofins Scientific has reported adjusted earnings that are up 19.
2% to 187 million euros, with adjusted EBITDA that is up 18.9% at 493 million euros for the first six months of 2020, meaning a 210-bp in its margin to 21.2%.
Despite a revenue shortfall in some laboratories due to lockdowns, the bioanalytical service provider's revenue increased by 7.2% to 2.32 billion euros, with organic growth of 5.1%.
Despite the uncertainties relating to the current situation, management is confident in the group's ability to achieve its 2020 targets, including 5% organic growth, revenue of 5 billion euros and adjusted EBITDA of 1.1 billion euros.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
2% to 187 million euros, with adjusted EBITDA that is up 18.9% at 493 million euros for the first six months of 2020, meaning a 210-bp in its margin to 21.2%.
Despite a revenue shortfall in some laboratories due to lockdowns, the bioanalytical service provider's revenue increased by 7.2% to 2.32 billion euros, with organic growth of 5.1%.
Despite the uncertainties relating to the current situation, management is confident in the group's ability to achieve its 2020 targets, including 5% organic growth, revenue of 5 billion euros and adjusted EBITDA of 1.1 billion euros.
Copyright (c) 2020 CercleFinance.com. All rights reserved.